Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Gongdong Medical Technology Co's revenue for the
three
months ended in Jun. 2026 was ¥299 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ¥1,167 Mil.
Zhejiang Gongdong Medical Technology Co's Revenue per Share for the
three
months ended in Jun. 2026 was ¥1.37.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ¥5.34.
Warning Sign:
Zhejiang Gongdong Medical Technology Co Ltd revenue per share has been in decline over the past 3 years.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Zhejiang Gongdong Medical Technology Co Revenue Related Terms
Zhejiang Gongdong Medical Technology Co Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Gongdong Medical Technology Co Revenue Chart
Zhejiang Gongdong Medical Technology Co Annual Data
For the Medical Instruments & Supplies subindustry, Zhejiang Gongdong Medical Technology Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Gongdong Medical Technology Co Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Gongdong Medical Technology Co's Revenue distribution charts can be found below:
* The bar in red indicates where Zhejiang Gongdong Medical Technology Co's Revenue falls into.
Zhejiang Gongdong Medical Technology Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,167 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Gongdong Medical Technology Co (SHSE:605369) has a Revenue of ¥1,167 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Zhejiang Gongdong Medical Technology Co and its competitors.
Is Zhejiang Gongdong Medical Technology Co's Revenue too high?
Zhejiang Gongdong Medical Technology Co's current Revenue is ¥1,167 Mil. Overall, Zhejiang Gongdong Medical Technology Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Gongdong Medical Technology Co's Revenue compare to ISRG and BDX?
Zhejiang Gongdong Medical Technology Co's Revenue of ¥1,167 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Zhejiang Gongdong Medical Technology Co and its competitors. Zhejiang Gongdong Medical Technology Co's current Revenue is ¥1,167 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Gongdong Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Gongdong Medical Technology Co (SHSE:605369) is currently considered Possible Value Trap. The stock's GF Value™ is ¥25.37, compared to a current price of ¥17.60 — trading 30.6% below its estimated fair value. The current Revenue is ¥1,167 Mil. Zhejiang Gongdong Medical Technology Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Zhejiang Gongdong Medical Technology Co (SHSE:605369), the current Revenue is ¥1,167 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Gongdong Medical Technology Co (SHSE:605369) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Gongdong Medical Technology Co stock appears to be undervalued.
The current stock price of ¥17.60 is trading 30.6% below its estimated GF Value™ of ¥25.37.
GuruFocus considers Zhejiang Gongdong Medical Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:605369:
Revenue: ¥1,167 Mil
GF Value™: ¥25.37 vs. price of ¥17.60 (30.6% below fair value)
No single metric tells the full story. See the SHSE:605369 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Gongdong Medical Technology Co Ltd is engaged in production and sales of disposable medical devices, and medical testing supplies. The company's products include Vacuum Blood collection system; Specimen Collection system; Petri Dish Family; Centrifugation Tube; Vaginal Speculum; Surgical Supplies; Pipette tip; Transfer Pipette; Test Tube; Test Tube Racks; and Colorimetric Cup.
76GF Score
Get the complete analysis for SHSE:605369
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:605369 has been successfully added to your 
